Get started
Author

Bo‐Cheng Huang

Observed name: Bo-Cheng Huang
OpenAlex ID: A5102384366
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity
2021 · Kai-Wen Ho, I.-J.u Chen, et al. · Journal of Nanobiotechnology · 31
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo
2024 · Yen-Ling Liu, Tzu-Yi Liao, et al. · Biomaterials Research · 13
Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy
2025 · Wen-Han Lee, Ying-Rou Shen, et al. · International Journal of Biological Macromolecules · 4
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
2025 · Tzu-Yi Liao, Yen-Ling Liu, et al. · International Journal of Biological Macromolecules · 4
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancer
2025 · Kai-Wen Ho, Yen-Ling Liu, et al. · International Journal of Biological Macromolecules · 2
Engineering tumor-specific interferon-alpha-Nivolumab pro-immunocytokine for enhanced melanoma immunotherapy
2026 · Shi-Wei Chao, Bo-Cheng Huang, et al. · International Journal of Biological Macromolecules · 1
Spatial‐hindrance‐based pro‐Adalimumab prevents anti‐idiotypic antibody interference in pharmacokinetic and therapeutic efficacy
2025 · Bo‐Cheng Huang, Yu‐Tung Chen, et al. · Bioengineering & Translational Medicine · 1
PDF
Bioengineered extracellular vesicles integrating anti-EphA2 recognition and oxaliplatin delivery for pancreatic cancer therapy
2026 · Shi-Wei Chao, Wan-Chi Tsai, et al. · Drug Delivery
PDF
Autologous hinge-masked anti-TNFα antibody to mitigate immunogenicity, antigen sink effects, and anti-idiotypic antibody interference
2026 · Bo-Cheng Huang, Yun-Chi Lu, et al. · Journal of Biological Engineering
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissue
2026 · Yu-Tung Chen, Zih-Yu Jhuang, et al. · Journal of Translational Medicine
Abstract 4333: A universal pro-immunocytokine platform using a spatial hindrance strategy to overcome MHC resistance and enhance efficacy
2026 · Chih-Hung Chuang, Shih-Ting Hong, et al. · Cancer Research
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events
2026 · Bo-Cheng Huang, Shih-Ting Hong, et al. · International Journal of Biological Macromolecules
Exploring boronate-appended hyperbranched amino-functionalized dendrimer-empowered sensors for the potential recognition of FSH in age-categorized human plasma samples
2025 · Sathyadevi Palanisamy, Priya Vijayaraghavan, et al. · Applied Materials Today
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization
2025 · En-Shuo Liu, Kai-Wen Ho, et al. · npj Vaccines
PDF
Corrigendum to “Selective activation of IFNγ–ipilimumab enhances the therapeutic effect and safety of ipilimumab” [Int. J. Biol. Macromol. 265(Pt 2) (Apr 2024) 130945]
2024 · Yi-Jung Huang, Kai-Wen Ho, et al. · International Journal of Biological Macromolecules
Works count: 15
Citation count: 56
H-index: 4
I10-index: 2
Year
Topic
Type